NFKB1 and lung adenocarcinoma: In the opposite, the lung adenocarcinomas with high KIAA1522 expression may be more willing to escape from cisplatin induced regression, which should be treated synergistically by NFκB inhibitor and platinum-based reagents to restore chemosensitivity.